Find your next paid study

M.D. Anderson Cancer CenterNCT05039632

Measuring Patient Reported Needs in Outpatient Liver Disease Management

This prospective study aims to assess health-related social needs (HRSNs) among patients with chronic liver disease (CLD) receiving outpatient care at Indiana …

Chronic Liver DiseaseCirrhosis, Liver

Indiana UniversityNCT07191886

Phase 3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

The purpose of this study is to assess the safety and efficacy of efimosfermin alfa in the resolution of steatohepatitis and improvement of liver-related clini…

Non-alcoholic Fatty Liver Disease

GlaxoSmithKlineNCT07221227

~$10 – $7,500

Supplementation of Pomegranate Dietary Supplements and Characterization of Urolithin Metabotypes in Patients With Alcohol Use Disorder (AUD) and Alcohol-associated Liver Disease (ALD)

The goal of this project is to determine an individual's ability to generate active gut microbial metabolites called urolithins upon consumption of pomegranate…

Alcohol Use DisorderAlcohol-associated Liver DiseaseAlcoholic Cirrhosis+1 more

University of LouisvilleNCT07678567

Critical IllnessPalliative CareOlder Adults+2 more

Improving Needs Among Older Adults: the ICUconnect 2 Primary Palliative Care RCT

Millions of older adults receive care in intensive care units (ICUs) annually. However, the quality and accessibility of ICU-based palliative care is highly va…

Duke UniversityNCT06588556

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver reg…

Liver CancerLiver Metastases

Maastricht University Medical CenterNCT07717437

Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverResectable Colorectal Carcinoma+4 more

Evaluation of Treatment Response of Colorectal Cancer Liver Metastases With Intravoxel Incoherent Motion Diffusion Weighted Imaging

This trial evaluates the treatment response of colorectal cancer that has spread to the liver (liver metastases) using intravoxel incoherent motion diffusion w…

M.D. Anderson Cancer CenterNCT04796818

Liver Transplant RecipientAlcohol Use Disorders (AUD)

Development and Testing of an Integrated Care Coordination Intervention for Alcohol Use Disorder Recovery After Liver Transplantation

The goal of this clinical trial is to learn if it is feasible and acceptable to use a recovery coach and an online sober active community to help with alcohol …

Leigh Anne DagefordeNCT07214259

~$10 – $8,750

Phase 1

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Study of Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers

Background: Drinking alcohol can lead to swelling and injury in the liver. Long-term heavy drinking may lead to liver disease. Researchers want to study the r…

Alcohol Associated Liver DiseaseHeavy Drinking Behavior

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NCT04781322

~$10 – $5,625

Prostate CancerRecurrent AdenocarcinomaLiver Cancer+1 more

Judging MR Simulation Procedures: A Phase I-II Study of the Use of Magnetic Resonance Imaging Simulation in the Planning of Radiation Treatments

This is a master protocol for a prospective Phase I-II study evaluating feasibility and efficacy of incorporating magnetic resonance imaging (MRI) simulation i…

Brigham and Women's HospitalNCT04545957

Breaking Health Care Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes

50 children/adolescents (ages 6 to \<18yrs) with T1D in suboptimal control (HbA1c≥8.0%) and lower SES (below 200% poverty line) on insulin therapy (either inje…

Diabetes Mellitus, Type 1ChildDelivery of Health Care+1 more

Nemours Children's ClinicNCT05849753

Phase 2

Peroxisome Proliferator-Activated Receptor Agonists to Prevent Primary Sclerosing Cholangitis Recurrence After Liver Transplantation

This study aims to determine the efficacy of 36 months once-daily fenofibrate in preventing clinically-detectable recurrence of primary sclerosing cholangitis …

Primary Sclerosing CholangitisLiver Transplant, ComplicationsPSC+1 more